Zhenjiang Li

5PUBLICATIONS
50CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 26, 2026
Integrative multi-omics of esophageal squamous cell carcinoma reveals immune alterations and lactylation-driven mechanisms in metastatic progression.

|Jan 03, 2025
Zanubrutinib plus R-CHOP for the treatment of newly diagnosed double-expressor lymphoma: A phase 2 clinical study.

Xia Yin, Qiang He, Dan Liu

|Jan 08, 2024
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study.

Yuqin Song, Zhengming Jin, Zhi-Ming Li

|Jun 27, 2023
A nomogram for predicting the rapid progression of diffuse large B-cell lymphoma established by combining baseline PET/CT total metabolic tumor volume, lesion diffusion, and TP53 mutations.

Cong Liu, Pengyue Shi, Zhenjiang Li

|Feb 03, 2023
The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial.

Tingyu Wang, Xiuhua Sun, Lihua Qiu

Pageof 1

Frequent Collaborators

2 joint publications

Xiuhua Sun

2 joint publications

Hang Su

2 joint publications

Zhiming Li

2 joint publications

Yuqin Song